Medicines A–Z
I
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Insulin hypurin® bovine protamine zinc injection | For existing patients only |
|
|
Insulin hypurin® porcine 30/70 injection | For existing patients only |
|
|
Insulin hypurin® porcine isophane injection | For existing patients only |
|
|
Insulin hypurin® porcine neutral inj (10ml) | For existing patients only |
|
|
Insulin insulatard® injection | Prescribe by brand name |
|
|
Insulin insuman® basal | Prescribe by brand name |
|
|
Insulin insuman® comb 15 injection | Prescribe by brand name |
|
|
Insulin insuman® comb 25 injection | Prescribe by brand name |
|
|
Insulin insuman® comb 50 injection | Prescribe by brand name |
|
|
Insulin insuman® rapid injection | Prescribe by brand name |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
